PeerView | Otolaryngology

Free CME from PeerView

Otolaryngology CME

Credits: 1.0 CME / MOC / CC / NCPD / CPE / AAPA / IPCE

PVI, PeerView Institute for Medical Education

Adapting Our Strategies for Decision-Making in Testing and Treatment of RET-Altered Lung and Thyroid Cancers: A Personalized Learning Journey

Professor Benjamin Solomon, MBBS, PhD, FRACP, FAHMS / Lori J. Wirth, MD

January 17, 2024

Credits: 1.5 CME / MOC / AAPA

PVI, PeerView Institute for Medical Education

Building on the Immunotherapy Foundation for Head and Neck Cancer: Lessons Learned, Practical Guidance, and Next Steps in Care

Barbara Burtness, MD

June 01, 2023

PVI, PeerView Institute for Medical Education

Refining Best Practices in Cancer Immunotherapy Biomarker Testing and Pathologic Response Assessment

Janis Taube, MD, MSc

March 01, 2023

PVI, PeerView Institute for Medical Education

Toward a Goal of Breathing Easy: Identifying Which of Your Patients With Chronic Rhinosinusitis With Nasal Polyps Can Benefit From Targeted Biologic Therapy

Anju T. Peters, MD, MS

October 06, 2022

PVI, PeerView Institute for Medical Education

Room to Breathe: Leveraging Biologic Agents and Multidisciplinary Care to Optimize Management in Chronic Rhinosinusitis With Nasal Polyps

Jivianne T. Lee, MD, FACS

September 27, 2022

PVI, PeerView Institute for Medical Education

Optimizing NTRK Fusion Testing and TRK Inhibition in Thyroid Cancer: Team-Based Approaches for Enhanced Outcomes

Marcia S. Brose, MD, PhD, FASCO

September 25, 2022

PVI, PeerView Institute for Medical Education

Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment

Alexander Drilon, MD

August 15, 2022

PVI, PeerView Institute for Medical Education

The Power and Promise of Immunotherapy in Head and Neck Cancer: How Established and Emerging Immune-Based Options Can Enhance Patient Care

Robert I. Haddad, MD

June 04, 2022